Abingdon Health signs MOU with Vatic Health and DeepVerge

0

Leading international developer of high quality and effective rapid tests Abingdon Health signed two Memorandums of Understanding (MoU) with Vatic Health and DeepVerge earlier today.

Vatic Health

Abingdon Health has signed a MoU with Vatic Health, a renowned diagnostic technology innovator. The MoU constitutes a commercial partnership between Abingdon and Vatic for the development and production of a range of lateral flow tests in the field of infectious disease, similar to those used in detecting Covid-19.

The initial focus of the MoU will be to create novel influenza lateral flow tests using Vatic’s patented technology platform, which recognises proteins through their surface biological processes.

Following the ratification of the MoU, Abingdon and Vatic intend to enter into a longer-term commercial agreement where both parties will develop infectious diseases lateral flow tests, with Abingdon exclusively manufacturing these tests. Both parties will collaborate on the commercialization of these innovative new products.

Alex Sheppard, Chief Executive Officer, Vatic Health Limited, said, “We are excited to be deepening our collaboration with Abingdon Health and we look forward to extending the use of our proprietary technology from COVID-19 into other areas of unmet need to further address inequalities of access to health information through self-tests.”

DeepVerge

DeepVerge is an ‘environmental and life science group’ that develops and applies artificial intelligence (AI) and internet of things (IoT) technology for the analysis and identification of bacteria, virus and toxins.

Abingdon Health announced the signing of a MoU with DeepVerge on Tuesday which will lead to a commercial agreement for the development and manufacturing.

The MoU was signed to allow DeepVerge and Abingdon’s technology to be integrated in the future.

Abingdon will manufacture the new products, while DeepVerge will commercialise them through its global production, sales, marketing, and distribution channels.

“DeepVerge’s business model is built on collaborating and cooperating with partners such as Abingdon Health who have technologies and large production capacity to deliver solutions to major societal problems such as water contamination and the identification of human biomarkers for a range of health conditions,” said Gerard Brandon, CEO of DeepVerge.

Abingdon Health’s shares lifted 9% to 11.7p following the announcement of 2 MoUs being signed.

Premier African Minerals completes Zulu Lithium DFS funding

0

Premier African Minerals saw its share price fall 4.5% to 0.3p in late afternoon trading on Tuesday after the company announced the completion of its Zulu Lithium Definitive Feasibility Study (DFS) funding.

Premier African Minerals reported its subscription agreement with Suzhou TA&A Ultra Clean Technology to raise £12 million prior to expenses at an issue price of 0.4p per new ordinary share in order to continue its Definitive Feasibility Study (DFS) at the company’s Lithium and Tantalum project.

The news followed Premier African Minerals’ announcement regarding the DFS funding on March 8 2022, in which CEO George Roach welcomed the subscription from Suzhou TA&A:

“I am delighted to accept this Subscription from Suzhou TA&A, and particularly that this makes available to Premier a wealth of expertise in this industry whilst aligning future offtake and mine development with Yibin Tianyi Lithium Industry Co. Ltd.”

“[The company] is a major producer of Lithium Hydroxides, financier and take-off partner for the Manono Lithium and Tin project and who have completed long term spodumene off-take agreements with Pilbara Minerals Limited.”

“I look forward to welcoming a new board member who will be nominated by Suzhou TA&A and active involvement from Suzhou TA&A in our DFS, particularly in the area of test work and flow sheet development.”

The company today announced the pending appointment of geologist Dr Luo Wei to its board of directors for Premier African Minerals, Zulu Lithium Mauritius Limited and Zulu Lithium Private Limited.

CEO George Roach commented positively on the outcome of the DFS funding in the reported update.

“I reiterate my welcome to our new shareholders and to Dr Lou Wei, and express my appreciation for the confidence in Premier and Zulu,” said Roach.

“Premier has already taken steps to expedite issues associated with resource definition needed to complete mine optimisation and test work and we will continue to accelerate all aspects of the DFS underway.”

Russia to ‘drastically reduce’ military attacks in Kyiv and Chernihiv

0

Russia’s deputy defence minister announced today that Russia will “drastically reduce” its military attacks around Ukrainian cities Kyiv and Chernihiv.

Financial Times’ journalist Max Seddon reported that Russia’s deputy defence minister said Moscow had chosen to “fundamentally cut back military activity in the direction of Kyiv and Chernihiv” in an attempt to “increase mutual trust for future negotiations to agree and sign a peace deal with Ukraine.”

The update followed negotiations between the embattled states, and comes on the back of several proposed terms including Ukraine adopting a neutral status in return for security guarantees, which would stop the country from joining any military alliances or hosting any military bases.

The negotiations also proposed a 15-year consultation period concerning the status of Crimea, which Russia annexed in 2014.

However, the proposal would only come to pass in the event of a total ceasefire.

“If we manage to consolidate these key provisions, and for us this is the most fundamental, then Ukraine will be in a position to actually fix its current status as a non-bloc and non-nuclear state in the form of permanent neutrality,” said Negotiator Oleksander Chaly in a statement on a Ukrainian television broadcast.

“We will not host foreign military bases on our territory, as well as deploy military contingents on our territory, and we will not enter into military-political alliances.”

“Military exercises on our territory will take place with the consent of the guarantor countries.”

Genedrive hearing loss test issued MIB from NICE

0

Genedrive shares gained 10% to 27.5p on Tuesday after the UK’s National Institute of Clinical Excellence (NICE) issued a new Medtech Innovation Briefing (MIB) on the Genedrive hearing loss test, MT-RNR1.

The near-patient molecular diagnostics company’s price rose despite Gendrive’s reported poor performance in their half-year results earlier today.

Genedrive recently launched its new Genedrive System for Antibiotic Induced Hearing Loss (AIHL). The test will identify the cause of life-long hearing loss through screening for genetic mutation.

The trial for AIHL was CE marked in December 2019 and completed performance trials at Manchester University NHS Trusts in June 2021.

The company deployed the Genedrive MT-RNR1 test in the UK and Ireland earlier this month to Manchester University Hospital Trust for routine use.

Genedrive reported no revenues in H2 2021 compared to £0.4m in 2020 due to delays in product development.

Genedrive saw an operating loss of £2.8m compared to £2.9m in 2020 with effective management of costs leading to a decline in R&D costs from £2.3m to £1.9m. The loss prevailed from the previous year due to the stockpiling of Genedrive96 SARS-COV-2 Kits.

The company incurred a cost of £14k due to interest charged for leasing the business’ principal premises.

The company noted a pre-tax loss of £2.8m in 2021 compared to £671k profits in 2020.

Genedrive is now debt-free and has a cash balance of £6.3m in 2021 compared to £3.8m in 2020, benefitting from £1.2m of R&D tax credit.

The company’s loss per share was 3.3p in 2021 compared to earnings per share of 1.9p in 2020.

David Budd, CEO, Genedrive, said, “We have achieved some key milestones in this period, namely the CE marking of our Genedrive POC COVID-19 test, which was closely followed by a number of distribution agreements with key territories.”

“We have also made significant further progress with our AIHL system, establishing initial installations and generating significant evidence and support to make commercial progress.”

Budd believes the company is “well positioned to deliver on shareholder value” as the company has carefully managed its cash position to continue expanding its portfolio.

Credit card debt soars as cost of living spikes

0

Credit card debt soared by £1.5 billion in February as the cost of living spiked across the UK, along with an additional £400 million in alternative borrowing, including personal loans and store cards.

The figures look grim for households as “awful April” looks set to eat into money which families can no longer afford to spare.

The £1.5 billion rise in credit card debt was noted as equal to the past five months of debt combined, and a dramatic change from the strongest period for pandemic savings which saw UK customers pay off almost £5 billion of credit card debt in just one month.

Consumers also only put aside an estimated £4 billion in savings compared to £7.2 billion in February.

The debt figure is looking set to climb as the cost of living increases over the coming months, bringing bad news for households already squeezed beyond their margins off the back of the Covid-19 pandemic, which has pummelled the economy for two years.

Chancellor Rishi Sunak announced a selection of small measures in his Spring Statement in a bid to help ease the pressure from households. However, his offerings of a £1 billion fund to assist vulnerable households with rising costs and his National Insurance threshold rise to £12,570 a year is unlikely to do a great deal to curb the bite of skyrocketing energy and consumer goods costs.

“The nation is clearly already feeling the effects of the cost of living crunch, with credit card use soaring in February as rising prices push more people into debt,” said AJ Bell head of personal finance Laura Suter.

“It’s worth noting that the Bank of England figures also don’t include any of the Buy Now Pay Later market, which has boomed in recent years and accounts for a big chunk of the credit we all take on.”

“This means that the nation’s debt figure will be much higher in reality, as people choose to defer paying for stuff they can’t afford today.”

“More households are going to have no spare money to put away each month and will have to start eating through their savings as ‘awful April’ hits and the squeeze on all our incomes ramps up.”

Nightcap – aiming to build the UK’s leading bars group

This company’s shares could double within the next eighteen months, as its profits take off.

It has taken advantage of the conditions that the Covid pandemic created and expanded impressively in a very short time.

Now it has built up three main branches to its business and it will use any one of them as its corporate growth strategy gathers pace.

Relative newcomer

Nightcap (NGHT.L) only floated on AIM in January last year, but it has subsequently shown itself to be an ambitious player in its particular part of the hospitality sector.

The company was set up in September 2020 with the purpose of using the significant changes that were taking place within the UK ‘premium bars’ segment, to acquire and grow a number of concepts through sensible and tight management.

Upon floating, with its shares at just 10p each, it had a £13.5m market capitalisation, raising £4m in the process before £1m of expenses.

The group’s management is very ably led by CEO Sarah Willingham, 47, who was involved in the expansion and growth of various hospitality sector groups, such as the Pizza Express, Clapham House Group and the Bombay Bicycle Club. 

She was also a Dragon on the panel of BBC’s ‘Dragon’s Den’, as well as a judge and investor on BBC Two’s ‘The Restaurant’ and ‘Cooks to Market’ series. She was a director and shareholder, with Raymond Blanc, in the London Cocktail Club and played a pivotal role in its growth.

Expansion strategy

The first Nightcap acquisition was the London Cocktail Club, an award-winning themed cocktail bar operation. It had nine London bars and one in Bristol, aimed at customers in the 26 to 40 years old age range.

The group, upon coming to the market, had a very straightforward corporate strategy – the acquisition of simple, replicable business models with nationwide roll-out potential.

Its timing could not have been better.

During Covid there was a big change in the hospitality sector, and so too in consumer preferences.

Expensive rents, growing capital expenditure costs, excessive discount offerings, increased food prices and the explosion of home delivery – all had impacted businesses within the sector.

Nightcap’s very experienced management team identified that the tastes of its millennial customers had moved significantly away from the offerings of the mid-market sticky-floored chains.

Instead, it was now evident that those customers looked for quality nights out in unique, local style venues.

And that is exactly where Nightcap has big ambitions.

Scalable brand growth

The difficulties in the property market suited Nightcap very well as it geared up its expansion programme, because its declared route was to acquire brands that were totally scalable and then roll out new branches.

In the last fifteen months Nightcap has shown its ability to do just that – so much so that it today has the declared aim to build the UK’s leading bar group.

May last year saw the group make its second major acquisition – that of the Adventure Bar Group, which took in some nine bars, seven of which were established theme bars in London, an outdoor venue bar and a planned bar in Birmingham. It also took on a 50% interest in a central London roof-top bar.

That month saw the group raise £10m through the Placing of some 43.5m new shares at 23p each.

The fresh funds swelled the group’s cash coffers, certainly enough to cover its roll-out and expansion plans for the next couple of years.

The opening of more Cocktail Club bars followed on, ahead of the November £5m purchase of the Barrio Familia group of Tequilla-led bars in London.

The last year or so has witnessed a fairly heady rate of expansion. The pace has been swift and opportunistic.

Three main brands

Today the group has three main brands upon which its expansion is based.

The Cocktail Club, which dropped the London tag suggesting its geographic capability, is an award-winning concept with 13 sites ready to scale up to 40 in London and major cities.

The Adventure Bar Group, has nine sites and is looking to roll out to 40 nationwide.

Barrio Bars, with five Latin-inspired Margarita and Tequila bars, again with significant roll out possibilities.

Landlords want Nightcap as a tenant

As Willingham and her team look at sites across the country, they now have the ability of assessing the potential of each set of premises, as to which could be right for any of its brands.

What is more, as this expansion progresses the group has the strength of its quote and more than sufficient cash in its coffers to fund the taking on of new locations. That must be like manna from heaven for property landlords, knowing that tenants are more than capable of meeting rental payments.

To attract such a tenant as Nightcap, many have actually given rent-free periods allowing it to establish the new venue for any of its brands, with some even offering shared capital expenditure to entice such a stable tenancy.

Recent interims show strength

The mid-March announced interim results to 26 December 2021, reported that the group had enjoyed strong trading with revenues leaping from £2.0m to £15.8m, while the loss before tax was up from £0.3m to £0.5m. At the period-end the group had some £9.4m in cash resources.

At the time Sarah Willingham stated that “Nightcap has had a fantastic half year. We have taken the first steps in significantly growing our family of bars, both by adding the Barrio Familia Group in November 2021 and by opening three more The Cocktail Clubs in Bristol, Reading and London. We finished the calendar year with 27 top-quality, late-night bars.”

Now the profits start to show through

Allenby Capital, the group’s broker, has predicted the current year to end June, will see group revenues explode from £5.97m to £34.38m, with profits of £2.07m against a previous £5.29m loss. Their analyst Matt Butlin considers that earnings will come in at 1.45p per share for the year.

But all that is nothing as compared to his estimates for the next two years.

Butlin goes for £54.39m sales in 2023, then £70.78m in 2024, while profits could rise to £5.27m and £7.53m respectively, taking earnings up to 2.53p then 3.40p per share.

Conclusion – a straight purchase ahead of June Pre-Close Trading Update

On the basis of those estimates, I believe that the £31m capitalised Nightcap group’s shares could easily double from the current 15.25p within the next year or so and still look very good value.

Small & Mid Cap Roundup: Aquis Exchange, Genedrive, Bellway, Tullow Oil

1

FTSE 250 was up 1.1% to 21,306 and the AIM index gained 0.5% to 1,043 in late morning trading on Tuesday on hopes of a market resurgence as Ukraine continued its peace talks with Russia.

FTSE 250 Risers

Mining company, Ferrexpo saw its shares fly 10% to 184p as it announced its support for Ukraine with its Humanitarian Fund update with the company supplying batteries for light vehicles, medical equipment and materials for temporary housing.

Tullow Oil shares gained 4% to 53p following the firm’s shares responding positively to completing the Azinam acquistion.

IWG shares rose 3.3% to 267p after the company announced a share buyback of 75,000 ordinary shares of 1p each at an average price of 259.68, representing 0.007% of issued share capital.

Liontrust Asset Management shares increased 3% to 1,272p following the confirmation of the acquisition of Majedie Asset Management.

888Holdings shares gained 1.3% to 191p after the announcement of their joint venture, 888Africa.

FTSE 250 Fallers

Property developer, Bellway saw its shares fall 5% as costs associated with building safety improvements rose to £22.1m. The company did however report a 3.5% increase in revenues followed by an 11.6% increase in underlying operating profits as the company noted a strong order book for 2022.

Bellway increased dividends from 35p to 45p in H1 2022 and currently has a 3x dividend cover.

“What hasn’t gone away are tight supply and demand dynamics and at least the housebuilders have taken the opportunity to fix the roof while the sun is shining,” said Russ Mould, Investment Director, AJ Bell.

“Most have strong balance sheets and Bellway is no exception with net cash of nearly £200 million. This may also support the ability to pay dividends to reward investors for their patience during any future market downturn.”

TP ICAP shares faded nearly 2% as the optimism around their recent update diminished.

AIM Fallers

Driver Group shares sunk almost 30% to 27.5p as the company revised their outlook for 2022 with a decrease in the group’s pre-tax profits from £1m to £300k – £500k for the half-year, following the company’s drop in revenues in the Middle East due to a ‘problematic loss-making contract’.

SkinBio Therapeutics shares plummeted 20% to 36.5p on Tuesday morning after the company announced pre-tax losses which nearly doubled to £1.16bn from £0.6bn in H1 2021. The firm also noted a slower than expected US market penetration in its half-year reports.

EQTEC saw its shares fall 9% to 1p following its announcement that it had obtained a new unsecured loan facility for up to £10m, with an initial advance of £5m to be received by 29 March 2022 from Riverfort Global Opportunities and YA II PN.

IQE also suffered with a drop of 4.4% to 39p as revenues decreased by 13% to £154k in 2021 as a result of the wireless and photonics segment’s revenues seeing a drop of 12% and 17% respectively.

Northamber shares fell 9.6% to 56.5p as the company recorded a pre-tax loss of £116k compared to a £230k profit in 2020 as distribution and administration costs pulled the group’s revenues down.

AIM Risers

Mobile Tornado Group shares soared 18% to 1.05p after the company extended its loan facility with InTechnology for an additional 12 months to September 26, 2023. The principal amount that can be drawn also increased from £300k to £500k.

Lansdowne Oil and Gas shares flew 18% to 0.65p a week after the company raised funds to develop the Barryroe prospect and provide working capital for the coming 6 months.

Near-patient molecular diagnostics company Genedrive shares gained 24% to 31p following the announcement from UK’s National Institute of Clinical Excellence (NICE) issuing a new Medtech Innovation Briefing (MIB) on the Genedrive MT-RNR1 test.

The shares gained despite Genedrive noting a pre-tax loss of £2.8m compared to profits of £621k in H1 2021 and stating a lack of revenues due to delays in product development.

Aquis Exchange shares increased 4% to 507p after the company noted an increase of 42% to £16.2m in revenues and its pre-tax profits soared 540% to £3.2m.

“I am delighted to be reporting such strong financial results today, with revenue up 42% and profit before tax increased in excess of five times from what we recorded in FY20,” said Alasdair Haynes, Chief Executive Officer, Aquis Exchange.

“It is clear we have now transformed into a business with dependable revenues, generating significant profits, and with a very robust financial position.”

“We have shown we are able to not only withstand periods of intense volatility and uncertainty, but to continue growing and investing throughout them. This gives us great confidence going forward.”

In addition to their AIM listing, Aquis have recently listed on their own Aquis Growth Market.

FTSE 100 rises on Ukraine peace talks hopes

0

The FTSE 100 was up 0.8% at 7,535.6 in late morning trading on Tuesday on peace talks between Russia and Ukraine, as the market held its breath for progress between the embattled states.

The price of oil fell on the back of the peace talks and China’s Covid-19 lockdown in Shanghai, with Brent Crude at $112 per barrel, after sanctions against Russia saw the price skyrocket above $120 per barrel earlier in March.

Shell’s share price increased 1.2% and BP’s share rose 0.3% despite the decline in oil prices.

“Having tripped over on Monday afternoon amid concern about China lockdowns and the conflict in Ukraine the FTSE 100 sprang back to its feet on Tuesday on hopes the latest round of peace talks between Moscow and Kyiv might yield tangible progress,” said AJ Bell investment director Russ Mould.

“The resilience of global stocks given the cocktail of risks facing the global economy is truly impressive but this stoicism is likely to face continuing tests as the impact of mounting prices and the actions of central banks continue to feed through, not to mention the ongoing geopolitical concerns.”

Prudential shares saw an increase of 3.7% to 1,116p. It’s possible that the insurance providers refocus on Asia has started to pay off on the back of the latest Covid-19 lockdown in China, potentially sparking a wave of insurance purchases in light of the uncertainty in the region.

Coca-Cola HBC enjoyed a rise of 3.1% to 1,6397p on the back of renewed peace talks between Russia and Ukraine. Coca-Cola HBC shares are the FTSE 100’s biggest faller so far in 2022, down 34%, after its Ukraine operations were disrupted by Russia’s invasion in February.

Fresnillo saw its shares increase 2.7% to 745.2p despite gold price falling.

Royal Mail Group shares declined 3.7% to 341.5p as it continued its downward spiral of 34.1% over the year-to-date.

Barclays was down 3.6% to 154.5p as an investor sold a £900 million stake at 150p following the bank’s announcement of its intent to buy back a slew of restructured notes at a loss of £450 million after it accidentally sold too many, delaying a scheduled £1 billion share buyback scheme.

B&M fell 2.4% to 545.5p following a recall of products due to the presence of harmful bacteria and glass fragments, such as its Parson’s Pickles Pickled Mussels according to a warning issued by the Food Standards Administration (FSA).

Downing Street set for 20 fines for ‘Partygate’

0

The Metropolitan Police are set to issue 20 fines this week to attendees of the “partygate” scandal, according to an announcement made earlier today.

Around 12 events were under investigation for Covid-19 breaches since January by the Metropolitan Police as MPs were known attendees of the events held in Downing Street and Whitehall during the lockdown.

Whitehall sources told BBC that the Met Police will issue 15 fixed-penalty fines initially and may start from Tuesday.

More fines are expected since around 100 people were given questionnaires by the Metropolitan Police for Operation Hillman, which is the name of the investigation.

Operation Hillman is investigating 12 events out of which Boris Johnson attended 3.

The PM had previously addressed the accusations and said that no rules were broken. Boris Johnson has returned his questionnaire however, his answers will not be made public. The PM did confirm, however, that he would disclose any fines imposed on him.

888 announces strategic African brand investment

0

888 saw its shares increase 0.3% to 189.2p in early morning trading on Tuesday following the announcement of its strategic “888Africa” brand investment in Africa.

The company reportedly signed an agreement with five “industry veterans” to form a joint-venture which will see the betting firm operate 888 brands across selected markets in Africa.

888 confirmed it has invested a minority stake in the venture with the option to increase its stake up to 100% and take control of the project.

888Africa is set to pay a brand license fee to operate 888’s brands in African markets, and will reportedly operate through a third-party technology platform with bespoke content and gaming for the local preferences of the region.

The joint-venture will be led by former Stars Group CMO Christopher Coyne, Voxbet Chairman Andrew Lee and former Editec Online CPO Alex Rutherford.

The project has also recruited former Stars Group Sportsbook Trading Director Ian Marmion and former Premier Bet CEO Helen Scott-Allen for its leadership team.

“We are delighted to launch 888Africa alongside 888,” said 888Africa CEO Christopher Coyne.

“With our team of experienced professionals and significant knowledge of the African markets, it is our ambition to build the business towards market-leading positions in selected regulated markets across the region.”

“Partnering with 888 will give us access to a world-class brand, as well as a broad team of experts to support our growth plans, further enhancing our confidence in our future prospects.”